197 related articles for article (PubMed ID: 36140779)
1. Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors.
Kulinczak M; Sromek M; Panek G; Zakrzewska K; Lotocka R; Szafron LM; Chechlinska M; Siwicki JK
Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140779
[TBL] [Abstract][Full Text] [Related]
2. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.
Zhou L; Wang W; Wang F; Yang S; Hu J; Lu B; Pan Z; Ma Y; Zheng M; Zhou L; Lei S; Song P; Liu P; Lu W; Lu Y
Mol Cancer; 2021 Mar; 20(1):57. PubMed ID: 33781255
[TBL] [Abstract][Full Text] [Related]
3. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
4. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
Liu W; Zhang B; Xu N; Wang MJ; Liu Q
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
[TBL] [Abstract][Full Text] [Related]
5. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
6. Correlation of MACC1/c-Myc Expression in Endometrial Carcinoma with Clinical/Pathological Features or Prognosis.
Zhang Q; Xu P; Lu Y; Dou H
Med Sci Monit; 2018 Jul; 24():4738-4744. PubMed ID: 29984790
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
Li L; Qu YW; Li YP
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of miR-203 in endometrial carcinomas.
Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
[TBL] [Abstract][Full Text] [Related]
10. p53 expression in tissue adjacent to endometrial carcinoma.
Shem EB; Fintsi Y; Avinoach I; Glezerman M; Menczer J
Eur J Gynaecol Oncol; 2002; 23(6):548-50. PubMed ID: 12556102
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
12. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
Wang Y; Dong L; Liu Y
Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
[No Abstract] [Full Text] [Related]
13. Expression of DJ-1 in endometrial cancer: close correlation with clinicopathological features and apoptosis.
Shu K; Xiao Z; Long S; Yan J; Yu X; Zhu Q; Mei T
Int J Gynecol Cancer; 2013 Jul; 23(6):1029-35. PubMed ID: 23727824
[TBL] [Abstract][Full Text] [Related]
14. Expressions and significances of TTF-1 and PTEN in early endometrial cancer.
Zhang HM; Fan TT; Li W; Li XX
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):20-26. PubMed ID: 28745797
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer.
Sinreih M; Hevir N; Rižner TL
Chem Biol Interact; 2013 Feb; 202(1-3):210-7. PubMed ID: 23200943
[TBL] [Abstract][Full Text] [Related]
16. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
17. Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas.
Buchynska LG; Brieieva OV; Iurchenko NP
Exp Oncol; 2019 Jun; 41(2):138-143. PubMed ID: 31262163
[TBL] [Abstract][Full Text] [Related]
18. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.
Bao W; Wang HH; Tian FJ; He XY; Qiu MT; Wang JY; Zhang HJ; Wang LH; Wan XP
Mol Cancer; 2013 Dec; 12():155. PubMed ID: 24321270
[TBL] [Abstract][Full Text] [Related]
19. Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
Ni J; Tian W; Liang S; Wang H; Ren Y
Int J Med Sci; 2021; 18(12):2510-2520. PubMed ID: 34104082
[No Abstract] [Full Text] [Related]
20. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
Song H; Li C; Lu R; Zhang Y; Geng J
Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]